Equities
Health CareMedical Equipment and Services
  • Price (USD)16.26
  • Today's Change0.405 / 2.55%
  • Shares traded24.95k
  • 1 Year change+3.36%
  • Beta0.7518
Data delayed at least 15 minutes, as of May 17 2024 20:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Olympus Corp grew revenues 6.16% from 881.92bn to 936.21bn while net income improved 69.12% from 143.43bn to 242.57bn.
Gross margin66.77%
Net profit margin2.88%
Operating margin4.66%
Return on assets1.77%
Return on equity3.81%
Return on investment2.51%
More ▼

Growth rates in JPY

Year on year, growth in dividends per share increased 20.87% while earnings per share excluding extraordinary items fell by -79.82%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend.
Div yield(5 year avg)0.40%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-79.08
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.